Merck Agrees To $220M Settlement In Vioxx Suit ST. LOUIS (AP) -- Drugmaker Merck & Co. Inc. could pay up to $220 million in the settlement of a class action lawsuit filed on behalf of Missouri consumers of the prescription pain reliever Vioxx. Attorney for the consumers, Patrick Stueve, says Thursday's agreement settles claims that New Jersey-based Merck violated the Missouri Merchandising Practices Act by promoting and selling the arthritis ... [News Source]